Lung Cancer Clinical Roundup
(Penn Medicine) Apr 15, 2021 - Real-word evidence is suggesting, for the first time, the most beneficial treatment courses that could help extend the lives of patients with metastatic non-small cell lung cancer, according to research from the Abramson Cancer Center at the University of Pennsylvania.
In a new study published online...
(MD Anderson) Apr 14, 2021 - Agreement builds on successful preclinical studies in gastrointestinal cancers through the joint Virtual Research and Development Center.
(Reuters) Apr 14, 2021 - AstraZeneca Plc said on Wednesday that China’s health regulator expanded the use of Tagrisso, the British drugmaker’s lung cancer treatment, in patients with a type of lung cancer when diagnosed at an early stage.
China’s National Medical Products Administration (NMPA) approved Tagrisso as an adjuvant...
(NIH) Apr 12, 2021 - Researchers from the National Institutes of Health have identified and tested a drug combination that exploits a weakness in small cell lung cancer (SCLC), an aggressive, dangerous cancer.
(ABC News/AP) Apr 12, 2021 - A drug that helps the immune system fight cancer gave dramatic results when used with chemotherapy before surgery in patients with operable lung tumors, doctors report.
One out of 4 patients given chemo and the Bristol Myers Squibb drug Opdivo had no signs of cancer remaining once they ultimately had...
Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center speaks with Melissa Johnson, MD, Program Director, Lung Cancer Research, Sarah Cannon Research Institute, discuss clinical progress in Small Cell Lung Cancer (SCLC)
Featured Episode of Leading Thoughts Series